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West Nile (WN) virus was first detected in North America
in the summer of 1999, during an epidemic and epizootic
involving humans, horses, and birds in the New York City
metropolitan area (1). The persistence and spread of the virus
to several neighboring states during the summer and fall of
2000 suggest that WN virus is now endemic in the United
States and that its geographic range probably will continue to
expand (2). Although many WN virus infections in humans
are asymptomatic or unrecognized, some patients have an
acute denguelike illness, and a small percentage have frank
meningitis and encephalitis (1-4). The latter complication is
most common among the elderly, with recent case-fatality
rates ranging from 4% to 11% (3-7).
WN virus is a positive-stranded RNA virus; based on its
antigenic and genetic characteristics, it is included in the
Japanese encephalitis (JE) serocomplex of the genus
Flavivirus, family Flaviviridae (8). WN virus was originally
isolated from a febrile patient in Uganda in 1937 (9), but it
has a worldwide geographic distribution, including most of
Africa, southern Europe, central and southern Asia, Oceania,
and now North America (3,4,7,10). Despite its wide
geographic distribution and frequency, little is known about
the pathogenesis of human infection with WN virus,
especially encephalitis. One unique pathologic finding in WN
virus encephalitis, unlike the encephalitides caused by other
closely related flaviviruses, is the targeting of Purkinje cells
of the cerebellum (1,7,11-13). We describe preliminary
studies of a hamster model for the disease.
Materials and Methods
Hamsters used in our studies were adult (70 to 100 g)
females (Mesocricetus auratus) obtained from Harlan
Sprague Dawley, Inc. (Indianapolis, IN). They were
experimentally infected with a single stock of WN virus strain
385-99. This virus was originally isolated from the liver of a
Snowy Owl that died at the Bronx Zoo during the 1999
epizootic in New York City (12); it had been passaged twice in
Vero cells.
Virus titrations were done by immunofluorescence
(Figure 1) in cultures of C6/36 cells (14) as described (15,16).
Blood and 10% brain homogenates were titrated in 24-well
tissue culture plates seeded with C6/36 cells. Serial 10-fold
dilutions from  10-1 to 10-6 were made of each sample in
phosphate-buffered saline containing 10% fetal bovine serum
(PBS); four wells were inoculated with 0.1 mL of each dilution.
The cells were subsequently examined for the presence of WN
virus antigen by indirect fluorescent antibody (IFA) test with
a WN virus-specific mouse immune ascitic fluid and a
commercially prepared (Sigma, St. Louis, MO), fluorescein-
conjugated, goat antimouse immunoglobulin (15,16). WN
virus titers were calculated as the tissue culture infectious
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Figure 1. West Nile virus antigen in infected C6/36 cells, as detected
by indirect fluorescent antibody testing.715 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
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dose50 (TCID50) per milliliter of specimen, as described by
Reed and Muench (17).
An initial study was done to determine the ID50 and the
lethal dose50 (LD50) of WN virus strain 385-99 for adult
hamsters. Serial 10-fold dilutions of the virus stock were
prepared from 10-1 to 10-6 in PBS, and groups of adult
hamsters were inoculated intraperitoneally with 0.1 mL of
the various dilutions of virus. Hamsters were observed for 28
days, and any deaths were recorded. Brain homogenates from
some of the dead animals were inoculated into cultures of
Vero or C6/36 cells, which were subsequently examined by
IFA to confirm the presence of WN virus. After 4 weeks, serum
specimens from surviving hamsters were examined by
hemagglutination-inhibition (HI) test for the presence of WN
virus antibodies. LD50 and ID50 values were calculated by the
method of Reed and Muench (17). In calculating the ID50 of
WN virus, both dead and seropositive animals were included.
In all subsequent experiments, hamsters were inoculated
intraperitoneally with a single virus dose of 104.0 TCID50.
Antibody Determinations
Antibodies to WN virus in the infected animals were
measured by HI and plaque reduction neutralization tests.
Antigens for the HI test were prepared from brains of newborn
mice infected with the prototype WN virus strain, B956 (9), by
the sucrose-acetone extraction method (18). Hamster sera
were tested by HI at serial twofold dilutions from 1:20 to
1:5,120 at pH 6.6, with 4 units of antigen and a 1:200 dilution
of goose erythrocytes (18).
The plaque reduction neutralization test was done in
microplate cultures of Vero cells as described (19), with a
constant virus inoculum (~100 PFU of the Egypt 101 WN
virus strain) against varying dilutions of hamster serum.
Hamster sera were prepared in twofold dilutions from 1:10 to
1:320 in PBS containing 10% fresh guinea pig serum. The
serum-virus mixtures were incubated overnight at 5°C before
inoculation. Two microplate wells were inoculated with each
serum dilution. Plaques were read on the sixth day; samples
producing  >90% plaque reduction were considered positive.
Histologic Examination of Tissues
Under Halothane (Halocarbon Laboratories, River Edge,
NJ) anesthesia, hamsters were exanguinated by cardiac
puncture. The chest cavity was opened quickly, and 20 to 30
mL of 10% buffered formalin was injected directly into the left
ventricle to perfuse the body. After refrigeration overnight at
5°C, the body was dissected, and samples of lung, liver,
spleen, pancreas, kidney, and spinal cord, as well as the entire
brain, were removed and placed in 10% buffered formalin
solution for another 24 hours to allow proper fixation. The
following day tissue samples were transferred to 70% ethanol
for storage. These specimens were subsequently processed,
and histologic slides were prepared as described (20). Special
stains (Luxol Fast Blue and Nissl’s) were also performed on
some brain and spinal cord sections. Tissues from six
uninfected hamsters were fixed and processed by the same
techniques; these tissues were included as controls in all
histologic and immunohistochemical examinations.
Immunohistochemical Detection of WN Viral Antigen
After deparaffinization, the formalin-fixed, paraffin-
embedded tissue sections (3- to 4-µm thick) were immersed in
3% H2O2 for 10 minutes to block endogenous peroxidase
activity. This was followed by an antigen retrieval heating
step, with a citrate buffer (10% target retrieval solution,
DACO, Carpinteria, CA), at 90°C for 30 minutes. A WN virus
immune ascitic fluid was used as the primary antibody at a
dilution of 1:100. A commercially available mouse-on-mouse
immunostain kit (InnoGenex, San Ramon, CA) was used to
detect specifically bound primary antibodies and prevent
nonspecific binding between species (20).
In Situ TUNEL Assay
The terminal deoxynucleotidyl transferase-mediated
dUTP nick-end labeling (TUNEL) technique was used to
assay for apoptosis in stained sections of hamster brain and
spinal cord, with the ApopTag peroxidase kit (Intergen
Company, Purchase, NY) and 3,3'-diaminobenzidine as the
chromogen (20). Slides were counterstained with hematoxylin
and mounted with a cover slip for microscopic examination.
Different regions of the section were evaluated individually.
For semiquantitative assessment of the apoptotic activity, a
single 20x-objective microscopic field was selected that
contained the highest number of positively stained cells. The
activity was scored as follows: 0 = no positive cells; 1 =  5
positive cells; 2 = 6 to 10 positive cells; 3 = 11 to 20 positive
cells; and 4 = >20 positive cells.
Results
An initial experiment was carried out to determine the
ID50 and LD50 of the 385-99 WN virus stock in adult female
hamsters following intraperitoneal inoculation (Table 1). The
hamster ID50 of the virus stock was estimated to be 10-6.3/mL
(17), but the LD50 was difficult to calculate because the
percentage of deaths at various dilutions did not give a clear
endpoint. A similar irregular pattern of death or encephalitis,
compared with the ID50, was also reported in hamsters
experimentally infected with tick-borne encephalitis (TBE)
virus (21). Based on these results, 104.0 TCID50 was selected
as the infecting dose of WN virus to be used in subsequent
hamster experiments.
The pattern of illness in the hamsters in all experiments
was similar. During the first 5 days after infection, the
hamsters appeared normal. At day 6 or 7, the animals became
lethargic and remained huddled together in the corners of
their cages. Food and water consumption by the animals
decreased, as did grooming activity. At days 7 to 10, many of
the animals had neurologic symptoms, including hind limb
paralysis, tremors, difficulty in walking, circling, and loss of
Table 1. Mortality and infection rates among adult hamsters following
intraperitoneal inoculation of serial 10-fold dilutions of West Nile virus
strain 385-99
Virus titer      No      No.     No.
of inoculuma inoculated infected (%) dead (%)
106.0 10 10 (100) 5 (50)
105.0 10 10 (100) 7 (70)
104.0 10 10 (100) 6 (60)
103.0 10   9 (90) 6 (60)
102.0 10   8 (80) 2 (20)
101.0 10   8 (80) 2 (20)
100.0 7   1 (14) 0 (0)
aTissue culture infectious dose50 (TCID50) as determined by titration in
mosquito cell (C6/36) cultures.716 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
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balance. Many of the severely affected animals died 7 to 14
days after infection. Animals still alive at 14 days usually
survived, although some had residual neurologic signs
(tremors, muscle weakness, and difficulty in walking).
Viremia and Antibody Response Following
WN Virus Infection of Hamsters
Figure 2 shows the pattern of viremia and immune
response in 10 adult hamsters following intraperitoneal
inoculation of 104 TCID50 of WN virus strain 385-99. These
animals were bled daily for 7 days. Moderate levels of viremia
were detected in the hamsters within 24 hours after infection;
viremia persisted for 5 or 6 days. HI antibodies were detected
in all the animals by day 5, and the titers continued to
increase through day 7 (Table 2). No infectious virus was
detected in the blood after day 6. The same pattern was
observed regardless of outcome (i.e., fatal encephalitis or
recovery). Titration of 10% brain suspensions of hamsters
that developed clinical encephalitis during the second week of
infection yielded virus titers ranging from 103 to 106.5 TCID50,
although no infectious virus was detected in peripheral blood
at this time and high titers of HI and neutralizing antibodies
were present in sera.
Pathologic Findings in Hamsters
with WN Virus Encephalitis
In a third experiment, 60 adult hamsters were inoculated
intraperitoneally with 104 TCID50 of WN virus strain 385-99.
Beginning on day 1 postinfection, two hamsters were killed
daily for 10 consecutive days; these animals were perfused
with 10% formalin to fix tissues for histologic study. Some
surviving animals from this experiment were subsequently
examined for persistent WN virus infection, as described later.
Histopathologic examination of liver, kidney, lung,
myocardium, pancreas, and spleen of the infected hamsters
during this initial 10-day period showed no substantial
pathologic changes, except for spotty splenic necrosis in a few
animals. In contrast, substantial, progressive pathologic
changes were observed in the brain and spinal cord.
During the first 4 days, no discernible pathologic changes
were observed in the brain or spinal cord. Beginning on day 5,
however, neuronal degeneration was seen in many areas,
manifested by shrinkage of the perikaryon with intense
eosinophilia of the cytoplasm, central chromatolysis, and
condensation of the nucleus. Small clusters of large neurons
undergoing these changes were located in the cerebral cortex,
cerebellar cortex (Purkinje cells), and subcortical gray
matter; the hippocampus and basal ganglia were also
affected, but less severely. No abnormalities were seen in the
spinal cord at this stage. These changes became more
extensive on day 6, with involvement of both the superficial
and deeper layers of the cerebral cortex, as well as the
hippocampus (Figure 3). Large neurons adjacent to the
olfactory bulb also showed similar degeneration. Likewise,
Purkinje cell degeneration in the cerebellum became more
severe and extensive, and scattered degenerating neurons
began to appear in the brain stem. At this stage, no
inflammatory cell infiltration or perivascular inflammation
was seen except for perivascular edema. However, mild
perivascular inflammation was observed in the spinal cord.
By days 7 and 8 postinfection, neuronal degeneration became
more localized, mainly involving the deeper layers of the
cerebral cortex, occasional large neurons in the olfactory
nucleus, scattered Purkinje cells in the cerebellum (Figure 3),
and the brain stem. At this stage, ill-formed microglial
nodules and minimal perivascular inflammation began to
appear. The microglial nodules consisted of small microglial
cells surrounding degenerative neurons (Figure 3). Mild
perivascular inflammation with focal neuronal degeneration
was observed in the spinal cord, mainly involving the anterior
horn. On day 9, more neuronal degeneration, along with
psammoma bodies, was seen in the olfactory nucleus; changes
in spinal cord were similar to those on day 8. On day 10, most
of the abnormalities were localized in the brain stem, which
exhibited focal neuronal degeneration surrounded by
microglial cell infiltration and “spongiform” neuropil (Figure
3F). Inflammation in the spinal cord was diffuse.
Brains from some surviving hamsters were also
examined pathologically on days 12, 14, 19, 28, 35, and 48
after infection. Microscopic changes observed included focal
loss of Purkinje cells, occasional microglial clustering, and
psammoma bodies.
Immunohistochemical Detection of WN Virus Antigen
WN virus antigen was not detected in the brain during
the first 5 days after inoculation. On day 6, clusters or
Figure 2. Daily mean (+ standard deviation) virus titers and hemag-
glutination inhibition antibody levels in 10 hamsters following intra-
peritoneal inoculation of 104 TCID50 of West Nile virus strain 385-99.
Table 2. Viremia and hemagglutination inhibition (HI) antibody response
in 10 adult hamsters following intraperitoneal inoculation of 104 TCID50
a
of West Nile virus strain 385-99
Ani-
mal
no. Day 1 Day 2 Day 3 Day 4 Day 5   Day 6   Day 7
8001 4.3(N)b 5.0(N) 5.0(N) 3.3(N) 1.0(80)  1.0(320) <0.7(640)
8002 4.7(N) 5.5(N) 5.2(N) 3.5(N) 2.0(80) <0.7(320) <0.7(640)
8003 5.3(N) 5.3(N) 5.0(N) 3.5(N) 2.5 (40) <0.7(320) <0.7(NT)
8004 2.0(N) 5.0(N) 5.0(N) 4.3(N) 2.5(40)  1.0(160) <0.7(640)
8005 4.0(N) 5.0(N) 5.5(N) 3.7(N) 1.7(80)  1.0(320) <0.7(1280)
8006 4.6(N) 5.2(N) 5.7(N) 4.3(N) 2.7(80) <0.7(320) <0.7(2560)
8007 4.3(N) 5.7(N) 4.6(N) 4.0(N) 2.0(80)  1.0(320) <0.7(2560)
8008 4.2(N) 5.8(N) 4.8(N) 1.8(N) 2.0(80) <0.7(320) <0.7(640)
8009 5.2(N) 5.2(N) 5.0(N) 3.2(N) 2.8(80) <0.7(320) <0.7(1280)
8010 4.7(N) 4.7(N) 5.5(N) 3.5(N) 1.8(80)  0.7(320) <0.7(1280)
aTCID50 = tissue culture infectious dose50
bLevel of viremia expressed as log10 TCID50 of virus/mL of blood. (reciprocal of
HI antibody titer) N = < 1:20.717 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
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individual neurons with antigen-positive cytoplasmic stain-
ing were observed in the basal ganglia and the brain stem
(Figure 4). Other regions of the brain were negative. By day 7,
the amount of antigen had increased, and antigen appeared in
neurons of the cerebellar cortex, subcortical gray matter,
brain stem, basal ganglia, and, to a lesser degree, in the
frontal and parietal cortices and the hippocampus. In the
cerebrum, foci of positive cells were more prominent
immediately adjacent to the ventricles. The amount of viral
antigen detected on days 8 and 9 decreased. By day 10 of
infection, antigen appeared focally (but strongly) only in
the brain stem (Figure 4). None of the hamsters had WN
virus antigen in the olfactory bulb by immunohistochemi-
cal staining.
Spinal cord sections from two hamsters were stained
immunohistochemically on day 9 postinfection. One or two
large neurons from each side of the anterior horn were
positive for WN virus antigen. The positive neurons were
limited in number but were present at most of the spinal levels
examined, particularly in the thoracic and lumbar regions.
Figure 3. Histologic changes in brains of West Nile virus-infected hamsters. a. Cerebral cortex, with many degenerating neurons, day 6
postinfection. b. Hippocampus, showing large neurons undergoing degeneration, day 6. c. Cerebellar cortex, with frequent Purkinje call
degeneration (shrunken cells, arrowheads) and loss, day 8. d. A microglial nodule near blood vessel in basal ganglia, day 9. e. Mild perivascular
inflammation (upper left field), neurons with nuclear condensation (arrowhead) and cytoplasmic eosinophilia, in brain stem, day 9. f.
Spongiform change in the brain stem, day 10. Magnification 100x.718 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
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In Situ TUNEL Assay
 The TUNEL assay, which selectively stains apoptotic
cells, was performed on both brain and spinal cord (22).
Apoptotic cells were observed in all the areas where neuronal
degeneration was seen histologically, but positive-staining
cells were most prominent in the hippocampus and basal
ganglia (Figure 5).
Brain sections from two or three hamsters from each day
postinfection were studied by this method (Figure 6). Rare
apoptotic cells began to appear on day 6, and activity
gradually increased and peaked on day 9. The positive cells
were not limited to neurons but included some endothelial
cells of blood vessels in the same microscopic fields. In
general, the concentration of apoptotic cells appeared to be
most intense in the basal ganglia and brain stem. High
activity also appeared transiently in the cerebellar cortex,
including both Purkinje cells and scattered medium-sized
neurons in the deeper levels (Figure 6).
Persistent WN Virus Infection in Hamsters
Because of an earlier report (23) that WN virus persisted
for up to 5½ months in the brains of experimentally infected
monkeys, we investigated this possibility in hamsters. Eleven
animals that survived intraperitoneal inoculation of WN
virus in the third experiment were killed at intervals of 19, 27,
35, 42, and 52 days after infection. A blood sample was taken
before death for culture and antibody determinations, and a
portion of the cerebellum was also removed at necropsy for
culture. WN virus was recovered in Vero cell cultures
inoculated with brain homogenates from 5 of 11 convalescent
hamsters sampled. WN virus was recovered from one of two
hamsters killed on day 19, one of two on day 27, one of two on
day 35, one of two on day 42, and one of three on day 52. The
positive cultures showed typical WN virus cytopathic effect
(CPE) and were confirmed by IFA with a WN virus immune
ascitic fluid. IFA of Vero cells from brain cultures without
CPE gave negative results. An attempt was made to titrate
some of the persistently infected brain samples in C6/36 cells,
but the titers were very low (<100.7 to 101.0 TCID50/mL of 10%
brain suspension). Blood cultures of the same hamsters were
negative, and the sera had high titers of HI and neutralizing
antibodies.
Conclusion
The sequence of events following intraperitoneal
inoculation of WN virus into adult hamsters was similar to
that described in experimental studies of other flavivirus
encephalitides (11,23-27). After a brief viremia of 5 to 6 days’
duration, humoral antibodies developed (Figure 2). During
this period, the hamsters were asymptomatic. Beginning
Figure 4. Immunohistochemical detection of West Nile virus antigen in brains of inoculated hamsters. The photomicrographs demonstrate
strong cytoplasmic staining (red color) of large and small neurons in different regions. a. Cerebral cortex, day 8 postinfection. b. Hippocampus,
day 7. c. Basal ganglia, day 7. d. Brain stem, day 10. Magnification: a-c 100x; d 50x.719 Vol. 7, No. 4, July–August 2001 Emerging Infectious Diseases
West Nile Virus
day 6 postinfection, many of the animals had clinical signs of
acute central nervous system (CNS) injury (somnolence,
muscle weakness, paralysis, tremors, and loss of balance)
with a substantial number of deaths occurring on days 7 to 14.
Histologically, neuronal degeneration in the brain also was
not seen until day 6 after infection. The histopathologic
changes began in the cerebral cortex, involving all layers, but
gradually only the deeper layers were involved. The observed
histopathologic changes eventually spread to the basal
ganglia, hippocampus, cerebellar cortex (as Purkinje cell
degeneration and loss), and brain stem. At first, neuronal
degeneration was not accompanied by microglial cell
infiltration or perivascular inflammation. These processes
appeared later, with well-formed microglial nodules,
sometimes containing a degenerating neuron at the center.
The in situ TUNEL analysis confirmed that many of the
degenerating neurons underwent apoptosis, leading to the
loss of these neurons. This observed sequence suggests that
WN virus entered the brain and infected neurons first and
that the inflammatory infiltration (perivascular inflamma-
tion and microgliosis) was a secondary response to neuronal
damage caused by the virus. Supporting this observation is
the fact that both histologic abnormalities and appearance of
Figure 5. In situ terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining (ApopTaq peroxidase kit, Intergen
Company, Purchase, NY) of neurons undergoing apoptotic cell death (brown-colored nuclear staining). a. Cerebellar cortex, showing occasional
positively stained Purkinje cells. b. Hippocampus. c. Positively stained neurons within a microglial nodule. d. Positively stained neurons in
cerebral cortex. Magnification 200x.
Figure 6. Semiquantitative analysis of ApopTaq-labeled cells in
different areas of the brain. Each area was scored individually on a
scale of 0 to 4 for positive staining intensity (see Materials and
Methods).
viral antigen (see below) were observed in the brain first and
spinal cord second.
Using immunohistochemical staining, WN virus antigen
was first detected in the brain on day 6 after infection. This
timing correlated well with the onset of encephalitic720 Emerging Infectious Diseases Vol. 7, No. 4, July–August 2001
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symptoms and the observed histopathology in the infected
hamsters. Viral antigen was detected in all the areas that
showed histologic lesions on routine hematoxylin and eosin
(H&E) staining, including cerebral cortex, deep cerebral
nuclei, hippocampus, basal ganglia, cerebellar cortex, and the
brain stem. Antigen positivity persisted longer in the brain
stem. The distribution of the WN virus antigen-positive cells
in the brain was focal; these cells usually formed discrete
clusters rather than a diffuse pattern. This focal distribution
may be caused by regional differences in blood-brain barrier
integrity or differential sensitivity of neurons. By day 10,
viral antigen was no longer detectable except focally in the
brain stem; it completely disappeared afterwards. No viral
antigen was detected in the olfactory nucleus in any of the
animals examined.
Despite frequent foci of WN virus antigen positivity and
neuronal degeneration, inflammatory cell infiltration (i.e.,
microglial nodules) was not prominent in the hamsters. As
shown by the in situ TUNEL analysis, many of the cells
undergoing apoptosis were not associated with inflammatory
cell attack. This observation suggests that cell death, caused
directly by WN virus infection, is the main mechanism of
neuronal damage. The exact mechanism by which WN virus
initiates the cell death pathway is not clear and will be the
subject of future studies. However, experimental studies with
Sindbis virus (genus Alphavirus, family Togaviridae) (28) and
neurovirulent dengue viruses (genus Flavivirus) (29) indicate
that these mosquito-borne viruses also cause encephalitis by
inducing neuronal apoptosis.
Many earlier experimental studies of WN encephalitis
were done in monkeys or mice (11,23,24,30-34). Monkeys are
no longer a viable option for most investigators because of
their cost and the regulatory issues involved in their use. The
histopathologic changes reported in the brain and spinal cord
of parenterally infected adult mice (24,31,32) are similar to
those observed in the WN virus-infected hamsters. However,
in preliminary studies with outbred adult Institute for Cancer
Research mice, we observed that the New York strain was
highly lethal by the intraperitoneal route, but that the
viremia following infection was minimal. Other investigators
have reported similar results with WN virus strains of Middle
Eastern or African origin (24,30,31,33). For this reason, we
decided to use hamsters as our animal model, since infection
in this rodent species seemed more similar to infection in
humans and horses (3,7).
Pogodina et al. (23,34) reported that both WN and tick-
borne encephalitis (TBE) viruses induce persistent infection
in the CNS of experimentally infected rhesus monkeys,
regardless of the route of inoculation or the symptoms (overt
or asymptomatic) of the acute infection. These investigators
showed that WN virus could be detected for up to 5½ months
in the CNS of monkeys after initial infection and that TBE
virus could be detected for up to 783 days after infection by
cocultivation of trypsinized brain cells on a monolayer of
indicator cells (23,34-36). Furthermore, the viruses recovered
from the persistently infected monkey brains differed in their
phenotypic characteristics (37). The aforementioned monkey
experiments were done more than 20 years ago, and the
phenotypically altered viruses were not characterized
genetically. However, our recovery of WN virus from the
brains of persistently infected hamsters supports this earlier
Russian work.
The studies of WN virus persistence in the brains of
experimentally infected hamsters were not carried beyond 52
days, so the duration and eventual outcome of chronic CNS
infection in the animals are unknown. WN virus was
recovered from the brains of 5 of 11 convalescent hamsters;
but in retrospect, the method of virus assay used (direct
culture of a crude brain homogenate) was probably not
optimal. Most of the surviving hamsters had WN virus-
neutralizing antibody titers >1:320 when tested 1-2 months
after infection. Since a homogenate of brain tissue inevitably
contains traces of blood that are present in small vessels,
antibodies in the blood may reduce the sensitivity of this
culture method (38). Consequently, the cocultivation
technique (36) of Pogodina et al. (35) or reverse-transcription
polymerase chain reaction would seem preferable, since these
assay methods reduce the inhibiting effect of antibodies.
Evidence of persistent infection and chronic progressive
neurologic disease following flavivirus encephalitis has been
described, especially with Japanese encephalitis and
members of the TBE complex (25,39-44). The mechanism and
sequelae of persistent CNS infection by flaviviruses are poorly
understood but may be of considerable public health
importance in the light of the frequency of human infection
with some of these agents. Our preliminary results suggest
that WN virus infection in hamsters may be a useful
experimental model for persistent flavivirus CNS infection.
The hamster also provides a reliable and inexpensive animal
model for study of the pathogenesis and treatment of WN
virus encephalitis.
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